Bionano Genomics Inc (MEX:BNGO)
MXN 5 -1.2 (-19.35%) Market Cap: 502.26 Mil Enterprise Value: 491.90 Mil PE Ratio: 0 PB Ratio: 0.35 GF Score: 46/100

Bionano Genomics Inc at Panel Testing and Susceptibility -- Clearing: Testing and Susceptibility -- Clearing the Air Transcript

May 27, 2020 / 04:00PM GMT
Jason Wesly McCarthy
Maxim Group LLC, Research Division - Senior MD

Okay. Welcome back, everybody, to our second panel. We just heard from some really, really interesting companies on the cell therapy side of COVID. We want to turn our attention now. So it's on so many people's minds these days, especially with everything reopening, enough testing. We need it. We really don't seem to have enough of it, but that is really changing, much of which you're going to hear from some of the companies on this panel today. So there's been a tremendous amount of availability and accessibility that these companies have contributed to. We're also learning a tremendous amount about susceptibility at the genomic level, we're going to hear a little bit about that. But there still seems to be a lot of confusion when you just talk to random people about where testing is in the space, then we're going to try to clear that air with this panel. So with that, I want to introduce our panelists, our presenting companies, who will reach out, give you a short presentation before we talk about everything that's going on in testing.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot